#9451. Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder

September 2026publication date
Proposal available till 10-05-2025
4 total number of authors per manuscript0 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Psychiatric Mental Health;
Clinical Psychology;
Psychiatry and Mental Health;
Medicine (miscellaneous);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
2510 $1340 $1170 $1000 $
Contract №9451.1 Contract №9451.2 Contract №9451.3 Contract №9451.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
Background: People with opioid use disorder (OUD) are disproportionately burdened by HIV. The United States Centers for Disease Control and Prevention (CDC) has issued guidelines for pre-exposure prophylaxis (PrEP) indication. We know little about PrEP for people receiving medication for OUD. The objective of this study is to report PrEP indication, awareness, and uptake in patients engaged in outpatient OUD treatment with buprenorphine. Methods: Adult patients (n = 137) receiving buprenorphine for OUD at an outpatient substance use disorder treatment clinic completed a cross-sectional survey between July and September 20XX. The study determined PrEP indication by 20XX CDC criteria. PrEP awareness and uptake were self-reported. The study assessed statistical differences in PrEP indicators by Pearsons ?2 and Fishers exact.
Keywords:
Buprenorphine; HIV prevention; Opioid use disorder; PrEP; Substance use disorder treatment

Contacts :
0